Genetic counselling of young women with breast cancer for Li-Fraumeni syndrome: a nationwide survey on the experiences and attitudes of genetics professionals

Familial Cancer
J J BakhuizenM G E M Ausems

Abstract

Germline TP53 mutations are associated with an increased risk of early-onset breast cancer. Traditionally, it was not standard practice to offer TP53 genetic testing due to the low mutation detection rate and limited options regarding preventive screening. Recent guidelines recommend that all women diagnosed with breast cancer before the age of 31, irrespective of family history, should be offered TP53 genetic testing. This study aims to gain more knowledge on the attitudes and experiences among genetics professionals regarding the timing and content of genetic counselling of young breast cancer patients for Li-Fraumeni syndrome (LFS). We conducted a nationwide online survey among genetics professionals who provide cancer genetic counselling in the Netherlands. Fifty-seven professionals completed the questionnaire (response rate overall 54%, clinical geneticists 70%). Most respondents reported that they discuss the option of TP53 genetic testing-simultaneously with BRCA 1/2-during the initial counselling visit, especially in case of referral for treatment-focused genetic counselling. There was a general consensus about ten information items that should be discussed during counselling. Sixty-one percent of genetics professionals...Continue Reading

References

Jun 1, 1990·American Journal of Epidemiology·E B ClausW D Thompson
Apr 29, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Fiona LallooD Gareth R Evans
Jun 12, 2008·Annual Review of Genomics and Human Genetics·Clare Turnbull, Nazneen Rahman
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kelly D GonzalezJeffrey N Weitzel
Aug 5, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie TinatThierry Frébourg
May 19, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chantal R M LammensEveline M A Bleiker
Aug 2, 2012·Familial Cancer·Jeanna M McCuaigDavid Malkin
Mar 20, 2014·Nature Reviews. Clinical Oncology·Kate A McBrideGillian Mitchell
May 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gaëlle BougeardThierry Frebourg
Mar 16, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nadine TungJudy E Garber
Jun 3, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christian P KratzDavid Malkin
Aug 5, 2017·JAMA Oncology·Marielle W G RuijsGabe S Sonke

❮ Previous
Next ❯

Software Mentioned

Research Online
Statistical Package for the Social Sciences ( SPSS )

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.